Assessment of variations in control of asthma over time
暂无分享,去创建一个
C Combescure | C. Combescure | P. Chanez | P. Godard | P. Saint-Pierre | J. Daures | H. Proudhon | P Chanez | J P Daurès | P Saint-Pierre | P Godard | H Proudhon
[1] R. Hill,et al. Description and evaluation , 1976 .
[2] D. Cockcroft,et al. Asthma control versus asthma severity. , 1996, The Journal of allergy and clinical immunology.
[3] J. Bousquet,et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. , 1987, The Journal of allergy and clinical immunology.
[4] N. Pride,et al. Clinical assessment of patients. , 1998, The European respiratory journal. Supplement.
[5] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[6] P. Barnes,et al. Changes in sputum eosinophils predict loss of asthma control. , 2000, American journal of respiratory and critical care medicine.
[7] C. Jenkins,et al. Diurnal variability—time to change asthma guidelines? , 1999, BMJ.
[8] Third Expert Panel on theDiagnosis,et al. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .
[9] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[10] J. Kalbfleisch,et al. The Analysis of Panel Data under a Markov Assumption , 1985 .
[11] L. Boulet,et al. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[12] B Wallaert,et al. Assessment of the severity of asthma by an expert system. Description and evaluation. , 1995, American journal of respiratory and critical care medicine.
[13] S. Durham,et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. , 1992, The American review of respiratory disease.
[14] J F Lawless,et al. Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. , 1994, Statistics in medicine.
[15] J. Vandenbroucke,et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.
[16] Barrett T. Kitch,et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. , 2001, The Journal of allergy and clinical immunology.
[17] J. Bousquet,et al. Is overall asthma control being achieved? A hypothesis-generating study. , 2001, The European respiratory journal.
[18] G. Crompton,et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.
[19] Pierre Ernst,et al. Canadian asthma consensus report, 1999 , 1999 .
[20] J. Daurès,et al. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis , 1999, British Journal of Cancer.
[21] J. Daurès,et al. [Modeling asthma evolution by a multi-state model]. , 2000, Revue d'epidemiologie et de sante publique.
[22] A. Buist,et al. Association of asthma control with health care utilization and quality of life. , 1999, American journal of respiratory and critical care medicine.
[23] D. Pfeffermann,et al. Small area estimation , 2011 .
[24] J. Ward,et al. Statistical analysis of the stages of HIV infection using a Markov model. , 1989, Statistics in medicine.